Clinical Trials Browser

Phase 1/2 × Lung Neoplasms × apatinib × Clear all

NCT04201990 2019-12-17

CCA-MPLC

Phase 1/2 Unknown

Lung Neoplasms

NCT03201146 2017-11-17

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms